InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.26
(
-0.76%
)
US TECH 100
19,649.60
(
0.08%
)
Dow Jones
42,740.42
(
-0.75%
)
Brent Oil
74.08
(
-0.53%
)
Bitcoin
67,405.07
(
0.59%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 61
Posts 11592
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: biophud post# 4466

Saturday, 12/08/2007 5:19:02 PM

Saturday, December 08, 2007 5:19:02 PM

Post# of 4764
Biophud,

Regarding the sale of the company:

I think it's still premature to think of a sale because of the way everything is evolving.

There are two major ph III crc adjuvant trials that will fully enroll in the 1st quarter of next year. Cetuximabs potential sales would be enormous in this setting, probably $2bil to $4bil even at a reduced priced.

We're waiting on CairoII, Coin and Crystal OS reports in 1st line crc.

We're waiting for the lung data.

The pipeline is just starting.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up